An international research team co-led by Vanderbilt University Medical Center has revealed how variations in gene regulation in different cell types drive pulmonary fibrosis, a progressive respiratory disorder characterized by scarring and loss of functional lung tissue.
Anna Hemnes, MD, professor of Medicine, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.
Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first phase 3, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID (LC), also known as long-haul COVID or post-acute sequelae of COVID-19. The study is funded by the National Institutes of Health’s National Institute on Aging.
Timothy Blackwell, MD, Rudy W. Jacobson Professor of Pulmonary Medicine and director of the Division of Allergy, Pulmonary and Critical Care Medicine, is leaving Vanderbilt University Medical Center to chair the Department of Internal Medicine at the University of Michigan. He assumes his new role on March 1.
Margaret Salisbury, MD, MS, a leader in the study and treatment of interstitial lung diseases at Vanderbilt University Medical Center, has received a Young Physician-Scientist Award from the Council of the American Society for Clinical Investigation (ASCI) for “notable achievements” in research.
Vanderbilt's Stokes Peebles, MD, has been appointed to the National Advisory Allergy and Infectious Diseases Council.
Department of Medicine Drs. Jonathan Brown (Cardiovascular Medicine) and Matthew Semler (Allergy, Pulmonary and Critical Care Medicine) are among three VUMC physicians who have been elected this year to membership in the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected medical honor societies.
